Deutsche Bank
IMNM icon

Deutsche Bank’s Immunome IMNM Stock Holding History

Deutsche Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
89,137
+12,895
+17% +$287K ﹤0.01% 1792
2025
Q4 		$1.64M Buy
76,242
+15,291
+25% +$268K ﹤0.01% 1910
2025
Q3 		$714K Buy
60,951
+7,209
+13% +$71.7K ﹤0.01% 2359
2025
Q2 		$500K Sell
53,742
-9,940
-16% -$81.5K ﹤0.01% 2460
2025
Q1 		$429K Buy
63,682
+17,607
+38% +$169K ﹤0.01% 2563
2024
Q4 		$489K Buy
46,075
+15,514
+51% +$187K ﹤0.01% 2623
2024
Q3 		$447K Buy
30,561
+8,535
+39% +$121K ﹤0.01% 2520
2024
Q2 		$267K Buy
22,026
+21,574
+4,773% +$337K ﹤0.01% 2660
2024
Q1 		$11.2K Buy
+452
New +$9.17K ﹤0.01% 3528
2021
Q2 		– Sell
-1,340
Closed -$45K – 4692
2021
Q1 		$45K Sell
1,340
-126
-9% -$3.13K ﹤0.01% 4259
2020
Q4 		$14K Buy
+1,466
New +$17.1K ﹤0.01% 4277

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Deutsche Bank's IMNM Position: Q1 2026 in Review

Deutsche Bank increased its Immunome (IMNM) stake by 17% in Q1 2026, buying an estimated $287K and bringing the position to 89,137 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Deutsche Bank first reported a position in IMNM in Q4 2020 and has held it in 11 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Deutsche Bank held 89,137 shares of Immunome worth $1.95M as of Q1 2026.
  • Deutsche Bank bought 12,895 Immunome shares in Q1 2026, an estimated $287K.
  • Immunome made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1792 holding.
  • Deutsche Bank first reported a position in Immunome in Q4 2020 and has held it in 11 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.